C
Consulta Portfolio holdings
AUM
$1.56B
This Quarter Return
+2.07%
1 Year Return
+11.02%
3 Year Return
+54.01%
5 Year Return
+90.66%
10 Year Return
+170.27%
AUM
$766M
AUM Growth
+$766M
(-2.9%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-5.92%
Top 10 Holdings %
Top 10 Hldgs %
90.18%
Holding
15
New
4
Increased
2
Reduced
6
Closed
1
Top Buys
| 1 |
Nike
NKE
|
$26.3M |
| 2 |
Wells Fargo
WFC
|
$22.1M |
| 3 |
Starbucks
SBUX
|
$20.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.9M |
| 5 |
DaVita
DVA
|
$6.61M |
Top Sells
| 1 |
Charter Communications
CHTR
|
$40.5M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$26.7M |
| 3 |
JPMorgan Chase
JPM
|
$21.7M |
| 4 |
Howard Hughes
HHH
|
$20M |
| 5 |
Allison Transmission
ALSN
|
$15.1M |
Sector Composition
| 1 | Financials | 26.99% |
| 2 | Healthcare | 25.08% |
| 3 | Communication Services | 19.42% |
| 4 | Real Estate | 10.84% |
| 5 | Technology | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HCA Healthcare
HCA
$94.5B
| $107M | 14.03% |
1,420,000
+70,000
| +5% | +$5.29M |
|
|
2
Berkshire Hathaway Class B
BRK.B
$1.09T
| $92.5M | 12.08% |
640,000
-185,000
| -22% | -$26.7M |
|
3
Comcast
CMCSA
$125B
| $87.9M | 11.48% |
1,325,000
| – | – |
|
|
4
Howard Hughes
HHH
$4.53B
| $83M | 10.84% |
725,000
-175,000
| -19% | -$20M |
|
|
5
DaVita
DVA
$9.85B
| $72.7M | 9.49% |
1,100,000
+100,000
| +10% | +$6.61M |
|
6
Sensata Technologies
ST
$4.74B
| $67.9M | 8.86% |
1,750,000
-250,000
| -13% | -$9.7M |
|
|
7
Charter Communications
CHTR
$36.3B
| $60.7M | 7.93% |
225,000
-150,000
| -40% | -$40.5M |
|
8
Visa
V
$683B
| $57.9M | 7.56% |
700,000
-50,000
| -7% | -$4.14M |
|
9
American International
AIG
$45.1B
| $34.1M | 4.46% |
575,000
| – | – |
|
|
10
Nike
NKE
$114B
| $26.3M | 3.44% |
+500,000
| New | +$26.3M |
|
|
11
Wells Fargo
WFC
$263B
| $22.1M | 2.89% |
+500,000
| New | +$22.1M |
|
|
12
Allison Transmission
ALSN
$7.3B
| $20.8M | 2.72% |
725,000
-525,000
| -42% | -$15.1M |
|
|
13
Starbucks
SBUX
$100B
| $20.3M | 2.65% |
+375,000
| New | +$20.3M |
|
|
14
Thermo Fisher Scientific
TMO
$186B
| $11.9M | 1.56% |
+75,000
| New | +$11.9M |
|
|
15
JPMorgan Chase
JPM
$829B
| – | – |
-350,000
| Closed | -$21.7M |
|